person · Reporting owner

Kaul Samir

Disclosed activity across 6 companies

Tapewire entity: 112196
SEC CIK: 0001501915

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Guardant Health, Inc.GH · Entity 3238	Director	June 14, 2023	June 16, 2023
Khosla Ventures Acquisition Co.KVSA · Entity 141683	Director · Chief Executive Officer · 10% owner	March 08, 2021	March 08, 2021
Khosla Ventures Acquisition Co. IIIKVSC · Entity 140787	Director · Chief Executive Officer · 10% owner	March 30, 2021	March 30, 2021
Vicarious Surgical Inc.RBOT · Entity 8714	Director · 10% owner	September 30, 2022	October 04, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Guardant Health, Inc.

Report date June 14, 2023 · Filed June 16, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
COMMON STOCKSEC Table I · non-derivative	Direct	11,404	Reported balance After 2023-06-14 transaction · row 1 1 source row Row 1 · 2023-06-14 · Exercise / conversion · Acquired 5,531 · Balance 11,404
RESTRICTED STOCK UNITSSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2023-06-14 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-06-14 · Exercise / conversion · Disposed 5,531 · Balance 0 F1: The restricted stock units vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier. F2: Not applicable for Restricted Stock Units.
RESTRICTED STOCK UNITSSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	5,592	Reported balance After 2023-06-14 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2023-06-14 · Grant · Acquired 5,592 · Balance 5,592 F4: The restricted stock units vest in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier. F2: Not applicable for Restricted Stock Units.
STOCK OPTION (RIGHT TO BUY)SEC Table II · derivative / convertible security · Conversion / exercise price $38.01 · Expires 2033-06-14	Direct	8,803	Reported balance After 2023-06-14 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2023-06-14 · Grant · Acquired 8,803 · Balance 8,803 F3: The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.

Filing footnotes · ownership attribution and instrument terms

F1: The restricted stock units vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier.

F2: Not applicable for Restricted Stock Units.

F3: The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.

F4: The restricted stock units vest in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.

Khosla Ventures Acquisition Co.

Report date March 08, 2021 · Filed March 08, 2021

Jointly reported with Khosla Ventures SPAC Sponsor LLC, Khosla Ventures SPAC Sponsor Services LLC, SK SPAC Services, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	990,000	Reported balance After 2021-03-08 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-03-08 · Grant · Acquired 990,000 · Balance 990,000 F1: Khosla Ventures SPAC Sponsor LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Khosla Ventures SPAC Sponsor LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.

Khosla Ventures Acquisition Co. III

Report date March 30, 2021 · Filed March 30, 2021

Jointly reported with Khosla Ventures SPAC Sponsor III LLC, Khosla Ventures SPAC Sponsor Services LLC, SK SPAC Services, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnote	1,426,605	Reported balance After 2021-03-30 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-03-30 · Grant · Acquired 126,605 · Balance 1,426,605 F1: Khosla Ventures SPAC Sponsor III LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Khosla Ventures SPAC Sponsor III LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.

Vicarious Surgical Inc.

Report date September 30, 2022 · Filed October 04, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	86,232	Reported balance After 2022-09-30 transaction · row 1 1 source row Row 1 · 2022-09-30 · Grant · Acquired 4,049 · Balance 86,232 F1: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $13,562 of cash retainer fees earned during the third quarter of 2022. The RSUs were fully vested on the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $13,562 of cash retainer fees earned during the third quarter of 2022. The RSUs were fully vested on the grant date.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Jack Creek Investment Corp.

Report date January 24, 2023 · Filed January 24, 2023

Section 16 reporting ended · disclosed 2023-01-24. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Ordinary Shares, par value $0.0001SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2023-01-24 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2023-01-24 · Disposition to issuer · Disposed 25,000 · Balance 0 F1: Pursuant to the Amended and Restated Memorandum and Articles of Association, as amended, of Jack Creek Investment Corp. (the "Issuer"), the Class B Ordinary Shares, par value $0.0001 per share ("Class B Shares"), of the Issuer, were automatically convertible into Class A Ordinary Shares, par value $0.0001 per share, of the Issuer, on a one-for-one basis, subject to adjustment, on the day of the closing of the Issuer's initial business combination. F2: In connection with the consummation of the business combination and other transactions contemplated by the Agreement and Plan of Merger, dated as of August 3, 2022, by and among the Issuer, Wildfire New PubCo, Inc. ("New Bridger"), and the other parties thereto, the Class B Shares were automatically exchanged for shares of common stock of New Bridger, which became a publicly traded company and which changed its name to Bridger Aerospace Group Holdings, Inc. upon the closing of the transactions.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Amended and Restated Memorandum and Articles of Association, as amended, of Jack Creek Investment Corp. (the "Issuer"), the Class B Ordinary Shares, par value $0.0001 per share ("Class B Shares"), of the Issuer, were automatically convertible into Class A Ordinary Shares, par value $0.0001 per share, of the Issuer, on a one-for-one basis, subject to adjustment, on the day of the closing of the Issuer's initial business combination.

F2: In connection with the consummation of the business combination and other transactions contemplated by the Agreement and Plan of Merger, dated as of August 3, 2022, by and among the Issuer, Wildfire New PubCo, Inc. ("New Bridger"), and the other parties thereto, the Class B Shares were automatically exchanged for shares of common stock of New Bridger, which became a publicly traded company and which changed its name to Bridger Aerospace Group Holdings, Inc. upon the closing of the transactions.

Nextdoor Holdings, Inc.

Report date November 05, 2021 · Filed November 09, 2021

Jointly reported with Khosla Ventures SPAC Sponsor II LLC, Khosla Ventures SPAC Sponsor Services LLC, SK SPAC Services, LLC

Section 16 reporting ended · disclosed 2021-11-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnote	11,364,957	Reported balance After 2021-11-05 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-11-05 · Conversion · Acquired 10,232,269 · Balance 11,364,957 F1: The Class B Common Stock automatically converted into shares of Class A Common Stock of the Issuer upon completion of the initial business combination on a one for 1.4694498 basis. F2: The Class K Common Stock automatically converted into 3,061,354 shares of Class A Common Stock of the Issuer upon completion of the initial business combination. F3: Khosla Ventures SPAC Sponsor II LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee Footnote	0	Reported balance After 2021-11-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-11-05 · Conversion · Disposed 4,880,000 · Balance 0 F1: The Class B Common Stock automatically converted into shares of Class A Common Stock of the Issuer upon completion of the initial business combination on a one for 1.4694498 basis. F3: Khosla Ventures SPAC Sponsor II LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.
Class K Common StockSEC Table II · derivative / convertible security	IndirectSee Footnote	0	Reported balance After 2021-11-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-11-05 · Conversion · Disposed 5,000,000 · Balance 0 F2: The Class K Common Stock automatically converted into 3,061,354 shares of Class A Common Stock of the Issuer upon completion of the initial business combination. F3: Khosla Ventures SPAC Sponsor II LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The Class B Common Stock automatically converted into shares of Class A Common Stock of the Issuer upon completion of the initial business combination on a one for 1.4694498 basis.

F2: The Class K Common Stock automatically converted into 3,061,354 shares of Class A Common Stock of the Issuer upon completion of the initial business combination.

F3: Khosla Ventures SPAC Sponsor II LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 14, 2023 Filed Jun 16, 2023 18:08 UTC	Guardant Health, Inc. GH · Entity 3238	GrantRESTRICTED STOCK UNITS · Derivative	5,592	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001576280-23-000097 · wk-form4_1686953316.xml · derivative · entry 4 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,592 Underlying: COMMON STOCK · 5,592 shares Expires not disclosed F4 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document
June 14, 2023 Filed Jun 16, 2023 18:08 UTC	Guardant Health, Inc. GH · Entity 3238	GrantSTOCK OPTION (RIGHT TO BUY) · Derivative	8,803	$0.00 Strike: $38.01	$0.00	Disclosure SEC source: 0001576280-23-000097 · wk-form4_1686953316.xml · derivative · entry 3 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,803 Underlying: COMMON STOCK · 8,803 shares Expires 2033-06-14 F3 · derivative.exercise_date: The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier. Read SEC document
June 14, 2023 Filed Jun 16, 2023 18:08 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionRESTRICTED STOCK UNITS · Derivative	5,531	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001576280-23-000097 · wk-form4_1686953316.xml · derivative · entry 2 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 5,531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document
June 14, 2023 Filed Jun 16, 2023 18:08 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	5,531	$0.00	$0.00	Disclosure SEC source: 0001576280-23-000097 · wk-form4_1686953316.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 24, 2023 Filed Jan 24, 2023 21:47 UTC	Jack Creek Investment Corp. JCIC · Entity 117689	Disposition to issuerClass B Ordinary Shares, par value $0.0001 · Derivative	25,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-23-002622 · form4.xml · derivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Shares, par value $0.0001 · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Pursuant to the Amended and Restated Memorandum and Articles of Association, as amended, of Jack Creek Investment Corp. (the "Issuer"), the Class B Ordinary Shares, par value $0.0001 per share ("Class B Shares"), of the Issuer, were automatically convertible into Class A Ordinary Shares, par value $0.0001 per share, of the Issuer, on a one-for-one basis, subject to adjustment, on the day of the closing of the Issuer's initial business combination. F2 · price: In connection with the consummation of the business combination and other transactions contemplated by the Agreement and Plan of Merger, dated as of August 3, 2022, by and among the Issuer, Wildfire New PubCo, Inc. ("New Bridger"), and the other parties thereto, the Class B Shares were automatically exchanged for shares of common stock of New Bridger, which became a publicly traded company and which changed its name to Bridger Aerospace Group Holdings, Inc. upon the closing of the transactions. F1 · derivative.exercise_date: Pursuant to the Amended and Restated Memorandum and Articles of Association, as amended, of Jack Creek Investment Corp. (the "Issuer"), the Class B Ordinary Shares, par value $0.0001 per share ("Class B Shares"), of the Issuer, were automatically convertible into Class A Ordinary Shares, par value $0.0001 per share, of the Issuer, on a one-for-one basis, subject to adjustment, on the day of the closing of the Issuer's initial business combination. F1 · derivative.expiration_date: Pursuant to the Amended and Restated Memorandum and Articles of Association, as amended, of Jack Creek Investment Corp. (the "Issuer"), the Class B Ordinary Shares, par value $0.0001 per share ("Class B Shares"), of the Issuer, were automatically convertible into Class A Ordinary Shares, par value $0.0001 per share, of the Issuer, on a one-for-one basis, subject to adjustment, on the day of the closing of the Issuer's initial business combination. Read SEC document
September 30, 2022 Filed Oct 4, 2022 10:12 UTC	Vicarious Surgical Inc. RBOT · Entity 8714	GrantClass A Common Stock	4,049	Not disclosed	Not disclosed	Disclosure SEC source: 0001213900-22-061579 · ownership.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,232 F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $13,562 of cash retainer fees earned during the third quarter of 2022. The RSUs were fully vested on the grant date. Read SEC document
June 30, 2022 Filed Jul 11, 2022 16:06 UTC	Vicarious Surgical Inc. RBOT · Entity 8714	GrantClass A Common Stock	4,613	Not disclosed	Not disclosed	Disclosure SEC source: 0001213900-22-038539 · ownership.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,183 F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $13,563 of cash retainer fees earned during the second quarter of 2022. The RSUs were fully vested on the grant date. Read SEC document
June 15, 2022 Filed Jun 17, 2022 17:54 UTC	Guardant Health, Inc. GH · Entity 3238	GrantRESTRICTED STOCK UNITS · Derivative	5,531	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001576280-22-000040 · wf-form4_165550287143417.xml · derivative · entry 5 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,531 Underlying: COMMON STOCK · 5,531 shares Expires not disclosed F5 · derivative.exercise_date: The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2023. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document
June 15, 2022 Filed Jun 17, 2022 17:54 UTC	Guardant Health, Inc. GH · Entity 3238	GrantSTOCK OPTION (RIGHT TO BUY) · Derivative	8,789	$0.00 Strike: $38.42	$0.00	Disclosure SEC source: 0001576280-22-000040 · wf-form4_165550287143417.xml · derivative · entry 4 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,789 Underlying: COMMON STOCK · 8,789 shares Expires 2032-06-14 F4 · derivative.exercise_date: The Stock Options vest in full on the one-year anniversary of the grant date, June 15th, 2023. Read SEC document
June 15, 2022 Filed Jun 17, 2022 17:54 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionRESTRICTED STOCK UNITS · Derivative	1,814	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001576280-22-000040 · wf-form4_165550287143417.xml · derivative · entry 3 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 1,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document
June 15, 2022 Filed Jun 17, 2022 17:54 UTC	Guardant Health, Inc. GH · Entity 3238	Exercise / conversionCOMMON STOCK	1,814	$0.00	$0.00	Disclosure SEC source: 0001576280-22-000040 · wf-form4_165550287143417.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 01, 2022 Filed Jun 3, 2022 16:21 UTC	Vicarious Surgical Inc. RBOT · Entity 8714	GrantClass A Common Stock	38,031	Not disclosed	Not disclosed	Disclosure SEC source: 0001213900-22-031151 · ownership.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,570 F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date. Read SEC document
March 31, 2022 Filed May 4, 2022 18:38 UTC	Vicarious Surgical Inc. RBOT · Entity 8714	GrantClass A Common Stock	2,510	Not disclosed	Not disclosed	Disclosure SEC source: 0001213900-22-024035 · ownership.xml · nonDerivative · entry 2 Kaul Samir · CIK 0001501915 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,539 F2 · price: RSUs granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of $12,700 of cash retainer fees earned during the first quarter of 2022. The RSUs were fully vested on the grant date. Read SEC document
December 31, 2021 Filed May 4, 2022 18:38 UTC	Vicarious Surgical Inc. RBOT · Entity 8714	GrantClass A Common Stock	1,320	Not disclosed	Not disclosed	Disclosure SEC source: 0001213900-22-024035 · ownership.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,029 F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of $14,555 of cash retainer fees earned during the third and fourth quarters of 2021. The RSUs were fully vested on the grant date. Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:38 UTC	Vicarious Surgical Inc. RBOT · Entity 8714	GrantClass A Common Stock	9,624	Not disclosed	Not disclosed	Disclosure SEC source: 0001213900-21-062141 · ownership.xml · nonDerivative · entry 2 Kaul Samir · CIK 0001501915 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,624 F2 · price: Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Kaul's continued service through the applicable vesting date. Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:38 UTC	Vicarious Surgical Inc. RBOT · Entity 8714	GrantClass A Common Stock	26,085	Not disclosed	Not disclosed	Disclosure SEC source: 0001213900-21-062141 · ownership.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,085 F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Kaul's continued service through the applicable vesting date. Read SEC document
November 05, 2021 Filed Nov 9, 2021 19:50 UTC	Nextdoor Holdings, Inc. KIND · Entity 5074	ConversionClass K Common Stock · Derivative	5,000,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-043708 · doc4.xml · derivative · entry 3 Kaul Samir · CIK 0001501915 · 10% owner Khosla Ventures SPAC Sponsor II LLC · CIK 0001846070 · 10% owner Khosla Ventures SPAC Sponsor Services LLC · CIK 0001848793 · 10% owner SK SPAC Services, LLC · CIK 0001848897 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 3,061,354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Class K Common Stock automatically converted into 3,061,354 shares of Class A Common Stock of the Issuer upon completion of the initial business combination. F2 · derivative.exercise_date: The Class K Common Stock automatically converted into 3,061,354 shares of Class A Common Stock of the Issuer upon completion of the initial business combination. F2 · derivative.expiration_date: The Class K Common Stock automatically converted into 3,061,354 shares of Class A Common Stock of the Issuer upon completion of the initial business combination. F3 · ownership.nature: Khosla Ventures SPAC Sponsor II LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein. Read SEC document
November 05, 2021 Filed Nov 9, 2021 19:50 UTC	Nextdoor Holdings, Inc. KIND · Entity 5074	ConversionClass B Common Stock · Derivative	4,880,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-043708 · doc4.xml · derivative · entry 2 Kaul Samir · CIK 0001501915 · 10% owner Khosla Ventures SPAC Sponsor II LLC · CIK 0001846070 · 10% owner Khosla Ventures SPAC Sponsor Services LLC · CIK 0001848793 · 10% owner SK SPAC Services, LLC · CIK 0001848897 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 7,170,915 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class B Common Stock automatically converted into shares of Class A Common Stock of the Issuer upon completion of the initial business combination on a one for 1.4694498 basis. F1 · derivative.exercise_date: The Class B Common Stock automatically converted into shares of Class A Common Stock of the Issuer upon completion of the initial business combination on a one for 1.4694498 basis. F1 · derivative.expiration_date: The Class B Common Stock automatically converted into shares of Class A Common Stock of the Issuer upon completion of the initial business combination on a one for 1.4694498 basis. F3 · ownership.nature: Khosla Ventures SPAC Sponsor II LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein. Read SEC document
November 05, 2021 Filed Nov 9, 2021 19:50 UTC	Nextdoor Holdings, Inc. KIND · Entity 5074	ConversionClass A Common Stock	10,232,269	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-043708 · doc4.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · 10% owner Khosla Ventures SPAC Sponsor II LLC · CIK 0001846070 · 10% owner Khosla Ventures SPAC Sponsor Services LLC · CIK 0001848793 · 10% owner SK SPAC Services, LLC · CIK 0001848897 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 11,364,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class B Common Stock automatically converted into shares of Class A Common Stock of the Issuer upon completion of the initial business combination on a one for 1.4694498 basis. F2 · price: The Class K Common Stock automatically converted into 3,061,354 shares of Class A Common Stock of the Issuer upon completion of the initial business combination. F3 · ownership.nature: Khosla Ventures SPAC Sponsor II LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein. Read SEC document
August 11, 2021 Filed Jan 7, 2022 16:36 UTC	Guardant Health, Inc. GH · Entity 3238	GiftCOMMON STOCK	5,000	$0.00	$0.00	Disclosure SEC source: 0001576280-22-000001 · wf-form5_164159139827200.xml · nonDerivative · entry 2 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 4,943 F1 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
June 16, 2021 Filed Jun 21, 2021 17:25 UTC	Guardant Health, Inc. GH · Entity 3238	GrantRESTRICTED STOCK UNITS · Derivative	1,814	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001576280-21-000068 · wf-form4_162431068986771.xml · derivative · entry 2 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,814 Underlying: COMMON STOCK · 1,814 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 16th, 2022. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document
June 16, 2021 Filed Jun 21, 2021 17:25 UTC	Guardant Health, Inc. GH · Entity 3238	GrantSTOCK OPTION (RIGHT TO BUY) · Derivative	3,135	$0.00 Strike: $117.19	$0.00	Disclosure SEC source: 0001576280-21-000068 · wf-form4_162431068986771.xml · derivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,135 Underlying: COMMON STOCK · 3,135 shares Expires 2031-06-15 F1 · derivative.exercise_date: The stock option vests in full on the one-year anniversary of the grant date, June 16th, 2022. Read SEC document
May 24, 2021 Filed Jan 7, 2022 16:36 UTC	Guardant Health, Inc. GH · Entity 3238	GiftCOMMON STOCK	5,000	$0.00	$0.00	Disclosure SEC source: 0001576280-22-000001 · wf-form5_164159139827200.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 9,943 F1 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
May 05, 2021 Filed May 7, 2021 16:41 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	300	$146.27	$43,881.00	Disclosure SEC source: 0001576280-21-000063 · wf-form4_162042007667326.xml · nonDerivative · entry 7 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 14,943 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.10 to $146.40 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
May 05, 2021 Filed May 7, 2021 16:41 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	300	$145.18	$43,554.00	Disclosure SEC source: 0001576280-21-000063 · wf-form4_162042007667326.xml · nonDerivative · entry 6 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 15,243 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.10 to $145.29 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
May 05, 2021 Filed May 7, 2021 16:41 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	900	$144.50	$130,050.00	Disclosure SEC source: 0001576280-21-000063 · wf-form4_162042007667326.xml · nonDerivative · entry 5 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 15,543 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.10 to $144.85 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
May 05, 2021 Filed May 7, 2021 16:41 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	1,405	$143.49	$201,603.45	Disclosure SEC source: 0001576280-21-000063 · wf-form4_162042007667326.xml · nonDerivative · entry 4 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 16,443 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.07 to $144.01 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
May 05, 2021 Filed May 7, 2021 16:41 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	500	$142.62	$71,310.00	Disclosure SEC source: 0001576280-21-000063 · wf-form4_162042007667326.xml · nonDerivative · entry 3 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 17,848 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.04 to $143.03 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
May 05, 2021 Filed May 7, 2021 16:41 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	300	$141.64	$42,492.00	Disclosure SEC source: 0001576280-21-000063 · wf-form4_162042007667326.xml · nonDerivative · entry 2 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 18,348 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.99 to $141.98 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
May 05, 2021 Filed May 7, 2021 16:41 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	1,295	$140.04	$181,351.80	Disclosure SEC source: 0001576280-21-000063 · wf-form4_162042007667326.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 18,648 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.63 to $140.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within each of the ranges set forth in this Form. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
April 05, 2021 Filed Apr 7, 2021 17:08 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	565	$159.85	$90,315.25	Disclosure SEC source: 0001576280-21-000038 · wf-form4_161782963320379.xml · nonDerivative · entry 5 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 19,943 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.69 to $159.97 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
April 05, 2021 Filed Apr 7, 2021 17:08 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	2,435	$159.18	$387,603.30	Disclosure SEC source: 0001576280-21-000038 · wf-form4_161782963320379.xml · nonDerivative · entry 4 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 20,508 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.69 to $159.68 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
April 05, 2021 Filed Apr 7, 2021 17:08 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	1,100	$158.21	$174,031.00	Disclosure SEC source: 0001576280-21-000038 · wf-form4_161782963320379.xml · nonDerivative · entry 3 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 22,943 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.67 to $158.61 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
April 05, 2021 Filed Apr 7, 2021 17:08 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	500	$156.95	$78,475.00	Disclosure SEC source: 0001576280-21-000038 · wf-form4_161782963320379.xml · nonDerivative · entry 2 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 24,043 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.66 to $157.30 inclusive. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
April 05, 2021 Filed Apr 7, 2021 17:08 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	400	$155.91	$62,364.00	Disclosure SEC source: 0001576280-21-000038 · wf-form4_161782963320379.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 24,543 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.48 to $156.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within each of the ranges set forth in this Form. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
March 30, 2021 Filed Mar 30, 2021 17:06 UTC	Nextdoor Holdings, Inc. KVSB · Entity 5074	GrantClass A Common Stock	32,688	$10.00	$326,880.00	Disclosure SEC source: 0000899243-21-013926 · doc4.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · Chief Executive Officer · 10% owner Khosla Ventures SPAC Sponsor II LLC · CIK 0001846070 · 10% owner Khosla Ventures SPAC Sponsor Services LLC · CIK 0001848793 · 10% owner SK SPAC Services, LLC · CIK 0001848897 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,132,688 F1 · ownership.nature: Khosla Ventures SPAC Sponsor II LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein. Read SEC document
March 30, 2021 Filed Mar 30, 2021 17:04 UTC	Khosla Ventures Acquisition Co. III KVSC · Entity 140787	GrantClass A Common Stock	126,605	$10.00	$1,266,050.00	Disclosure SEC source: 0000899243-21-013925 · doc4.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · Chief Executive Officer · 10% owner Khosla Ventures SPAC Sponsor III LLC · CIK 0001845858 · 10% owner Khosla Ventures SPAC Sponsor Services LLC · CIK 0001848793 · 10% owner SK SPAC Services, LLC · CIK 0001848897 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,426,605 F1 · ownership.nature: Khosla Ventures SPAC Sponsor III LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein. Read SEC document
March 26, 2021 Filed Mar 26, 2021 18:08 UTC	Khosla Ventures Acquisition Co. III KVSC · Entity 140787	GrantClass A Common Stock	1,300,000	$10.00	$13,000,000.00	Disclosure SEC source: 0000899243-21-013724 · doc4.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · Chief Executive Officer · 10% owner Khosla Ventures SPAC Sponsor III LLC · CIK 0001845858 · 10% owner Khosla Ventures SPAC Sponsor Services LLC · CIK 0001848793 · 10% owner SK SPAC Services, LLC · CIK 0001848897 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,300,000 F1 · ownership.nature: Khosla Ventures SPAC Sponsor III LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein. Read SEC document
March 26, 2021 Filed Mar 26, 2021 18:08 UTC	Nextdoor Holdings, Inc. KVSB · Entity 5074	GrantClass A Common Stock	1,100,000	$10.00	$11,000,000.00	Disclosure SEC source: 0000899243-21-013723 · doc4.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · Chief Executive Officer · 10% owner Khosla Ventures SPAC Sponsor II LLC · CIK 0001846070 · 10% owner Khosla Ventures SPAC Sponsor Services LLC · CIK 0001848793 · 10% owner SK SPAC Services, LLC · CIK 0001848897 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,100,000 F1 · ownership.nature: Khosla Ventures SPAC Sponsor II LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein. Read SEC document
March 08, 2021 Filed Mar 8, 2021 16:05 UTC	Khosla Ventures Acquisition Co. KVSA · Entity 141683	GrantClass A Common Stock	990,000	$10.00	$9,900,000.00	Disclosure SEC source: 0000899243-21-010331 · doc4.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director · Chief Executive Officer · 10% owner Khosla Ventures SPAC Sponsor LLC · CIK 0001846071 · 10% owner Khosla Ventures SPAC Sponsor Services LLC · CIK 0001848793 · 10% owner SK SPAC Services, LLC · CIK 0001848897 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 990,000 F1 · ownership.nature: Khosla Ventures SPAC Sponsor LLC ("Sponsor") is the record holder of the shares reported herein. Khosla Ventures SPAC Sponsor Services LLC is the owner of Sponsor. VK Services LLC and SK SPAC Services, LLC are the joint owners of Khosla Ventures SPAC Sponsor Services LLC. Vinod Khosla and Samir Kaul are the managing members of VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by Sponsor. Each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein. Read SEC document
December 22, 2020 Filed Feb 12, 2021 16:59 UTC	Guardant Health, Inc. GH · Entity 3238	GiftCOMMON STOCK	27,000	$0.00	$0.00	Disclosure SEC source: 0001576280-21-000016 · wf-form5_161316717262993.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 24,943 F1 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
October 16, 2020 Filed Oct 20, 2020 16:20 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	1,575	$103.21	$162,562.05	Disclosure SEC source: 0001628280-20-014611 · wf-form4_160322522035357.xml · nonDerivative · entry 3 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 51,943 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $102.82 to $103.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
October 16, 2020 Filed Oct 20, 2020 16:20 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	3,215	$102.19	$328,532.17	Disclosure SEC source: 0001628280-20-014611 · wf-form4_160322522035357.xml · nonDerivative · entry 2 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 53,518 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $101.82 to $102.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
October 16, 2020 Filed Oct 20, 2020 16:20 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	5,210	$101.29	$527,699.02	Disclosure SEC source: 0001628280-20-014611 · wf-form4_160322522035357.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 56,733 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $100.82 to $101.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
September 17, 2020 Filed Sep 21, 2020 17:18 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	1,200	$102.26	$122,714.76	Disclosure SEC source: 0001628280-20-013792 · wf-form4_160072307507433.xml · nonDerivative · entry 4 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 61,943 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $101.83 to $102.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
September 17, 2020 Filed Sep 21, 2020 17:18 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	4,514	$101.14	$456,566.27	Disclosure SEC source: 0001628280-20-013792 · wf-form4_160072307507433.xml · nonDerivative · entry 3 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 63,143 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $100.80 to $101.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
September 17, 2020 Filed Sep 21, 2020 17:18 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	3,286	$100.35	$329,757.33	Disclosure SEC source: 0001628280-20-013792 · wf-form4_160072307507433.xml · nonDerivative · entry 2 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 67,657 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $99.80 to $100.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
September 17, 2020 Filed Sep 21, 2020 17:18 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	1,000	$99.23	$99,226.00	Disclosure SEC source: 0001628280-20-013792 · wf-form4_160072307507433.xml · nonDerivative · entry 1 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 70,943 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $98.80 to $99.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
August 17, 2020 Filed Aug 19, 2020 17:37 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	500	$89.44	$44,717.50	Disclosure SEC source: 0001628280-20-012890 · wf-form4_159787303348486.xml · nonDerivative · entry 5 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 71,943 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F7 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $89.32 to $89.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document
August 17, 2020 Filed Aug 19, 2020 17:37 UTC	Guardant Health, Inc. GH · Entity 3238	SaleCOMMON STOCK	2,277	$88.71	$201,985.61	Disclosure SEC source: 0001628280-20-012890 · wf-form4_159787303348486.xml · nonDerivative · entry 4 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 72,443 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $88.30 to $89.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.